Ms. Peeraphan Compiro | Biotechnology | Young Scientist Award
PhD student, Chulalongkorn University Thailand
Peeraphan Compilo is a Ph.D. candidate in Bioinformatics and Computational Biology at Chulalongkorn University, Bangkok, Thailand. With expertise in genetic techniques, bioinformatics, and molecular biology, Peeraphan has conducted innovative research on CRISPR-Cas12a-based detection of Mycobacterium spp. She has a strong academic background in Genetics and Medical Biochemistry, along with hands-on experience as a Research Assistant and Teaching Assistant. Peeraphan is skilled in advanced programming and bioinformatics tools, fostering groundbreaking contributions in molecular microbiology. Her publications reflect a deep commitment to advancing medical diagnostics and biotechnology, particularly for infectious diseases.
Publication Profile
š Education
Ph.D. in Bioinformatics and Computational Biology (2024-present): Chulalongkorn University; Advisor: Dr. Pornchai Kaewsapsak. M.Sc. in Medical Biochemistry (2021-2023): Chulalongkorn University; Focus on CRISPR-Cas12a; Advisor: Dr. Pornchai Kaewsapsak. B.Sc. in Genetics (2017-2021): Chulalongkorn University; Specialized in mutagenesis and microbial biotechnology; Advisor: Assist. Prof. Dr. Chompunuch Glinwong. Relevant Courses: Biostatistics, Bioinformatics, Programming, and Probability.
š¼ Experience
Research Assistant (2024-present): Center of Excellence in Systems Microbiology (CESM). Teaching Assistant (2023): Faculty of Medicine, Chulalongkorn University. Trainee (2020): National Center for Genetic Engineering and Biotechnology, Enzyme Technology Lab. Research Projects: CRISPR-Cas12a detection systems and gene mutagenesis for microbial biotechnology applications.
š Awards & Honors
Published in Clinica Chimica Acta (2024) and Procedia of Multidisciplinary Research (2023). Presented innovative CRISPR-based diagnostic tools for Mycobacterium spp. at international conferences. Recognized for interdisciplinary research combining computational biology and genetics.
š¬ Research Focus
Conclusion
Publication Top Notes
- CRISPR-Cas12a-based detection and differentiation of Mycobacterium spp
- Published: Clinica Chimica Acta, 2024
- Authors: P. Compiro, N. Chomta, J. Nimnual, S. Sunantawanit, S. Payungporn, and others
- This study focuses on the use of CRISPR-Cas12a for the detection and differentiation of various Mycobacterium species, advancing diagnostic accuracy for diseases like tuberculosis.
- Identification of Mycobacterium tuberculosis using CRISPR-Cas12a
- Published: Procedia of Multidisciplinary Research, Vol. 1 (7), pp. 102-102, 2023
- Author: P. Compiro
- This work explores the application of CRISPR-Cas12a technology in the identification of Mycobacterium tuberculosis, demonstrating its potential as a rapid and precise diagnostic tool.